225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome Interventions: Biological: Actinium Ac 225-DOTA-Daratumumab; Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Biological: Daratumumab; Procedure: Echocardiography; Drug: Fludarabine; Procedure: Hematopoietic Cell Transplantation; Biological: Indium In 111-DOTA-Daratumumab; Drug: Melphalan; Procedure: Multigated Acquisition Scan; Procedure: Radionuclide Imaging; Procedure: Single Photon Emission Computed Tomography; Drug: Sirolimus; Drug: Tacrolimus; R...
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
Conditions: Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Sponsors: Siriraj Hospital; Faculty of Medicine Siriraj Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Registry of Haploidentical Hematopoietic Stem Cell Transplantation in Adult with Hematologic Disease
Conditions: Hematologic Patients with Haploidentical Hematopoietic Stem Cell Transplantation Sponsors: Siriraj Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Improvement of Women's Health After Allogeneic Stem Cell Transplantation
Conditions: GVHD, Chronic Sponsors: Ciusss de L ' Est de l ' Île de Montréal; Centre hospitalier de l ' Universit é de Montréal (CHUM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
Conditions: Multiple Myeloma; Exercise; Prehabilitation Interventions: Behavioral: Supported Exercise; Behavioral: Standard Care Sponsors: University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
Conditions: Graft-versus-host-disease; Graft Versus Host Disease, Chronic; Stem Cell Transplant Complications; Hematological Malignancy; Hematologic Cancer Interventions: Other: Physical therapy Sponsors: University of Seville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Hematological Diseases Interventions: Behavioral: AlloCare Sponsors: Rigshospitalet, Denmark; Danish Cancer Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
ALLOGENIC ADIPOSE-DERIVED MESENCHYMAL STEM CELLS (AMSCs) FOR EPILEPSY DURING DEEP BRAIN STIMULATION (DBS) SURGERY
Conditions: Epilepsy Interventions: Drug: AMSCs Sponsors: Sanjeet S. Grewal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Experience with a hybrid recruitment approach of patient-facing web portal screening and subsequent phone and medical record review for a neurosurgical intervention trial for chronic ischemic stroke disability (PISCES III)
ConclusionsA tiered approach to eligibility screening using a hybrid of web-based portals to self-identify and screen for general eligibility followed by a more detailed phone and medical record review allowed the study to use fewer sites and reduce cost. Despite the difficult and narrow population of patients suffering moderate chronic disability from stroke, this strategy produced a viable recruitment rate for this invasive study of intracranially injected neural stem cells.Trial registrationClinicalTrials.gov Identifier: NCT03629275 (Source: Trials)
Source: Trials - February 28, 2024 Category: Research Source Type: clinical trials
Late Effects and Health Related Quality of Life in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation - a Cross Sectional Study
Conditions: Hematological Diseases Sponsors: Rigshospitalet, Denmark; Danish Cancer Society Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD
Conditions: Chronic Obstructive Pulmonary Disease Sponsors: China-Japan Friendship Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Conditions: Chronic Graft Versus Host Disease; Hematopoietic and Lymphatic System Neoplasm Interventions: Procedure: Biospecimen Collection; Procedure: Echocardiography; Drug: Ibrutinib Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.
Conditions: Bronchopulmonary Dysplasia Interventions: Biological: Control; Biological: Allogenic fetal mesenchymal stem cells from umbilical cord - three infusions; Biological: Allogenic fetal mesenchymal stem cells from umbilical cord - six infusions Sponsors: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Implementation of a Protocol for the Transdifferentiation of Buccal Mucosal Epithelium Into Corneal Epithelium
Conditions: Limbal Stem Cell Deficiency Interventions: Procedure: Conjunctival reconstruction Sponsors: University Hospital, Montpellier; Institute for Neuroscience Montpellier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
Conditions: Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferative Disorders Interventions: Drug: ATG dosing platform when combined with standard tacrolimus and mini methotrexate Sponsors: University of Alabama at Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
